secwatch.observer — SEC 8-K summary
======================================

Issuer:     EAGLE PHARMACEUTICALS, INC. (—)
CIK:        0000827871
Form:       8-K
Filed at:   2024-10-31T23:59:59+00:00
Accession:  0001104659-24-112887
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 1.01, 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eagle Pharma adopts poison pill after Nasdaq delisting; triggers at 10% ownership
--------------------------------------------------------------------------------

- Rights plan adopted with 10% (15% for passives) trigger; rights expire Oct 30, 2025.
- Common stock delisted from Nasdaq Oct 3, 2024; now trades on OTC Expert Market under EGRX.
- Stockholders of record Nov 11, 2024 receive one right per share; exercise price $10.00.
- Company cites significant trading price dislocation and unsolicited third-party accumulations.
- Board continues review of financing alternatives to address liquidity and capital structure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/827871/000110465924112887/0001104659-24-112887-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/827871/000110465924112887/tm2427095d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-112887

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer